No image published for this recall

No image published for this recall

Atellica system

Official notice

14 Mar 2022

Last checked

14 Mar 2022

Medium riskHealth Canada

An official Health Canada notice concerns Atellica system. Siemens Healthcare Diagnostics Inc. Has confirmed customer observations of falsely elevated results when using plasma specimens across the entire analytical measuring range (AMR) with the Atellica IM enhanced estradiol (EE2) assay. Results demonstrate that plasma specimens are not meeting claims as defined in the instructions for use (IFU). Limited data is available at this time as the investigation for this issue is on-going. Recall start date: Mar 9, 2022 Published 2022-03-14.

What to do now

Contact the manufacturer if you require additional information.

Recall number

63995

Official notice

2022-03-14

The hazard

Siemens Healthcare Diagnostics Inc. Has confirmed customer observations of falsely elevated results when using plasma specimens across the entire analytical measuring range (AMR) with the Atellica IM enhanced estradiol (EE2) assay. Results demonstrate that plasma specimens are not meeting claims as defined in the instructions for use (IFU). Limited data is available at this time as the investigation for this issue is on-going. Recall start date: Mar 9, 2022

How to check if you're affected

Compare the product name and identifiers below with the item you own. Follow the official notice if they match.

Recall Numbers

63995

Checked manually this time?

The app alerts you when a new official recall is published — no searching, no checking back.

Turn on recall alerts

Affected products

Product 1

Affected Products - Atellica Im Enhanced Estradiol (Ee2), Lot or Serial Number - All lots., Model or catalog number - 10995562, 10995561

Product 2

Affected Products - Advia Centaur System - Enhanced Estradiol (Ee2) Assay, Lot or Serial Number - All lots., Model or catalog number - 10490889, 10491445

Product 3

Affected Products - Advia Centaur Cp System - Enhanced Estradiol (Ee2) Assay, Lot or Serial Number - All lots., Model or catalog number - 10490889, 10491445

Risk / hazard

Siemens Healthcare Diagnostics Inc. Has confirmed customer observations of falsely elevated results when using plasma specimens across the entire analytical measuring range (AMR) with the Atellica IM enhanced estradiol (EE2) assay. Results demonstrate that plasma specimens are not meeting claims as defined in the instructions for use (IFU). Limited data is available at this time as the investigation for this issue is on-going. Recall start date: Mar 9, 2022

Where it was sold

The source does not list specific retailers. See the official notice for where affected products were sold.

Location 1

CA · Canada

Affected area 1

CA · Canada

Company & contacts

Manufacturer

Not provided

Phone

Not provided

Brand: Siemens, Atellica System.

Source & status

Source

Health Canada

Tier

official

Category

HEALTH

Classification

Type II

App estimate

medium

Recall details

Recall number

63995

Classification

Type II

Source tier

official

Documents, notices & source

See the official notice and source documents for full details.

View full official notice
Something wrong on this page?

Weekly recall digest

Get next week's recalls before you need them.

One email every Monday — official-source recalls for your country, and nothing else. Unsubscribe from any email.

The digest is the slow lane — one email a week. For instant, severity-gated alerts the moment a notice is published, get the app.

This recall was published 14 Mar 2022. The next one won't wait for you to search.

RecallScope watches official sources for the brands and VINs you follow, and alerts you the moment a new notice is published.